Nous vous informons que ce site est conforme à la législation française actuelle sur les dispositifs médicaux.
Nanobiotix announces closing of the global offering and full exercise of underwriters’ option to purchase additional ADSs, bringing gross proceeds of global offering to $113.3 million
Nanobiotix announces closing of the global offering and full exercise of underwriters’ option to purchase additional ADSs, bringing gross proceeds of global offering to $113.3 million
